The Future of Immunotherapy in the Treatment of Cancer
- PMID: 31477413
- DOI: 10.1016/j.soncn.2019.08.013
The Future of Immunotherapy in the Treatment of Cancer
Abstract
Objectives: To discuss future direction and present an overview of the evolution of immunotherapy long-term toxicity issues, financial toxicity, and new emerging survivorship considerations.
Data sources: Peer-reviewed manuscripts, Web sites.
Conclusion: Cancer treatments involving immunotherapy have had a major impact on long-term survival, toxicity, and survivorship issues.
Implications for nursing practice: Nurses play a pivotal role in the care of the cancer patient across the continuum. With the unique toxicities associated with immunotherapy, it is essential that nurses be keenly aware of all aspects of management, from physical to financial care.
Keywords: CAR T-cell therapy; Fertility; Financial toxicity; Immune checkpoint inhibitors; Immune related adverse events; Survivorship; T-VEC.
Copyright © 2019. Published by Elsevier Inc.
Publication types
MeSH terms
LinkOut - more resources
Medical